Objective:

To outline practical strategies for using patient assistance programs to reduce medication costs for glaucoma patients.

Approach:

Key Findings:

• Manufacturer-sponsored assistance programs can significantly reduce costs but are limited to certain insurance types.
• Discount platforms allow price comparisons but do not contribute to deductibles.
• Online pharmacies may offer lower prices but have formulary limitations.
• Compounding pharmacies can provide cost advantages but require careful oversight.
• Specialized pharmacies can improve medication adherence for patients with disabilities.

Interpretation:

The complexity of the pharmaceutical pricing system necessitates a structured approach to assist patients in managing their medication costs effectively.

Limitations:

• Assistance programs often exclude patients on Medicare or Medicaid.
• Discounted purchases do not count towards deductibles.
• Online pharmacies may not carry all necessary medications.

Conclusion:

Clinicians should implement small structural changes within their practices to better support patients in navigating drug costs, including designating a 'drug access champion.'

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.